Lesson Plan: Sepsis — Recognition, Management, and Clinical Judgment

Learning Objectives

By the end of this lesson, BSN-4 students will be able to:

1. Define sepsis, severe sepsis, and septic shock using the Sepsis-3 consensus criteria (Remember — AACN D2, NCLEX PhysI).
2. Explain the pathophysiological cascade from localized infection to systemic inflammatory response and multi-organ dysfunction (Understand — AACN D2).
3. Apply the qSOFA screening tool and interpret SOFA scores to identify patients at risk for sepsis-related organ dysfunction (Apply — AACN D3, NCLEX PhysI).
4. Perform a priority-focused nursing assessment for a patient presenting with suspected sepsis, including recognition of early and late clinical manifestations (Apply — AACN D3, QSEN PCC).
5. Implement the Surviving Sepsis Campaign Hour-1 Bundle in the correct sequence, including specimen collection, antibiotic administration, and fluid resuscitation (Apply — AACN D6, QSEN S, NCLEX PI).
6. Analyze hemodynamic monitoring data, serum lactate trends, and end-organ function indicators to evaluate treatment response (Analyze — AACN D8, NCLEX BCC).
7. Prioritize nursing interventions for a patient in septic shock who is deteriorating despite initial resuscitation, including escalation of vasopressor therapy and escalation of care (Analyze — AACN D6, NCLEX SECE).
8. Design an individualized patient and family education plan addressing sepsis prevention, recognition of recurrence, and post-sepsis syndrome (Create — AACN D2, QSEN PCC).

---

Background and Clinical Significance

Sepsis is one of the leading causes of mortality in hospitalized patients worldwide, responsible for more than 270,000 deaths annually in the United States alone and accounting for more than $62 billion in annual healthcare costs. Despite decades of research, sepsis remains one of the most challenging conditions to recognize and manage, largely because its presentation is heterogeneous and its progression can be rapid and unpredictable. For fourth-year BSN students entering advanced clinical practice, a comprehensive understanding of sepsis pathophysiology, diagnostic criteria, and evidence-based management is not optional — it is a core clinical competency.

The 2016 Sepsis-3 Task Force redefined sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, replacing earlier definitions that relied primarily on the Systemic Inflammatory Response Syndrome (SIRS) criteria. This shift in definition reflects the current understanding that the harm in sepsis arises not solely from the infecting organism but from the body’s own pathological immune response. The nurse at the bedside is frequently the first clinician to detect early warning signs, making nursing assessment and rapid escalation essential to improving patient outcomes.

---

Definitions and Diagnostic Criteria (Sepsis-3)

Sepsis

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Organ dysfunction is identified using the Sequential (Sepsis-Related) Organ Failure Assessment (SOFA) score, with a change of ≥ 2 points from baseline indicating clinically significant dysfunction.

Septic Shock

Septic shock is a subset of sepsis in which underlying circulatory, cellular, and metabolic abnormalities are severe enough to substantially increase mortality. Patients with septic shock are identified by all three of the following:

• A suspected or confirmed infection
• A vasopressor requirement to maintain a mean arterial pressure (MAP) ≥ 65 mmHg
• A serum lactate > 2 mmol/L despite adequate volume resuscitation

qSOFA — Rapid Bedside Screening Tool

The quick SOFA (qSOFA) is a simple, validated bedside tool that requires no laboratory values. A score of ≥ 2 should prompt further evaluation for organ dysfunction and consideration of ICU-level care.

Parameter	Score
Respiratory rate ≥ 22 breaths/min	1
Altered mental status (GCS < 15)	1
Systolic blood pressure ≤ 100 mmHg	1
Total	0–3

SOFA Score — Organ Dysfunction Assessment

The full SOFA score evaluates six organ systems. A score ≥ 2 above baseline confirms organ dysfunction consistent with sepsis.

Organ System	Parameters Evaluated
Respiratory	PaO₂/FiO₂ ratio
Coagulation	Platelet count
Hepatic	Bilirubin
Cardiovascular	MAP or vasopressor requirement
Neurological	Glasgow Coma Scale
Renal	Creatinine or urine output

---

Pathophysiology

From Local Infection to Systemic Dysregulation

Sepsis begins when a localized infection (most commonly bacterial, but also fungal or viral) overwhelms the host’s containment mechanisms. The sequence unfolds as follows:

Pathogen-associated molecular patterns (PAMPs) — components of bacterial cell walls such as lipopolysaccharide (LPS) — are recognized by pattern-recognition receptors (e.g., Toll-like receptors) on immune cells. This triggers activation of the innate immune system and a massive release of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). In health, this response is self-limiting and protective. In sepsis, it becomes dysregulated and generalized, leading to:

• Endothelial dysfunction: Widespread endothelial injury increases capillary permeability, causing protein and fluid to shift into the interstitium (third spacing), resulting in intravascular hypovolemia even as total body fluid may be normal or elevated.
• Vasodilation and maldistribution of blood flow: Nitric oxide release causes profound vasodilation and reduces systemic vascular resistance (SVR), leading to distributive shock. Blood flow is shunted away from vital organs even when cardiac output may be elevated early in the process.
• Microvascular thrombosis and coagulopathy: Simultaneous activation of coagulation pathways and consumption of clotting factors can lead to disseminated intravascular coagulation (DIC), further compromising end-organ perfusion.
• Mitochondrial dysfunction: At the cellular level, oxygen delivery and utilization become uncoupled. Even when tissue oxygenation is restored, cells may be unable to use oxygen effectively (cytopathic hypoxia), as reflected by persistently elevated serum lactate.

Hemodynamic Phases

Phase	Cardiac Output	SVR	Clinical Presentation
Early (Warm)	↑ or normal	↓↓	Warm flushed skin, bounding pulse, fever, tachycardia
Late (Cold)	↓↓	↑↑	Cool mottled skin, weak pulse, hypotension, obtundation

Organ Systems at Risk

As perfusion fails, end-organ dysfunction develops in a characteristic pattern:

• Lungs: Acute Respiratory Distress Syndrome (ARDS) — diffuse alveolar damage from inflammatory mediators; presents as refractory hypoxemia despite oxygen therapy.
• Kidneys: Sepsis-associated Acute Kidney Injury (SA-AKI) — oliguria, rising creatinine, metabolic acidosis; most common organ to fail.
• Liver: Hyperbilirubinemia, elevated transaminases, coagulopathy from reduced clotting factor synthesis.
• Heart: Septic cardiomyopathy — reversible myocardial depression even without underlying coronary disease.
• Brain: Sepsis-associated encephalopathy — delirium, agitation, altered consciousness without direct CNS infection.
• Coagulation: DIC — simultaneous microvascular clotting and hemorrhage; elevated PT/INR, low platelets, elevated D-dimer, low fibrinogen.

---

Nursing Assessment

History and Risk Factors

A thorough but rapid history should identify the likely source of infection and patient risk factors for deterioration. Common infectious sources (by mnemonic LUMEN):

• L — Lungs (pneumonia — most common source)
• U — Urinary tract (UTI/urosepsis)
• M — Meninges / CNS
• E — Enteric / abdominal (peritonitis, cholangitis, bowel perforation)
• N — Non-specific / skin and soft tissue (cellulitis, wound infections)

Risk factors for poor outcomes include: age > 65, immunosuppression (cancer, transplant, HIV, corticosteroids), diabetes mellitus, chronic kidney disease, recent surgery, indwelling devices (central lines, urinary catheters), and malnutrition.

Physical Assessment — Early vs. Late Manifestations

System	Early Sepsis	Late Sepsis / Septic Shock
Cardiovascular	Tachycardia, bounding pulse, warm skin	Hypotension (SBP < 90), weak thready pulse, mottling
Respiratory	Tachypnea (RR > 20), mild dyspnea	ARDS, SpO₂ < 90% despite high-flow O₂
Neurological	Anxiety, restlessness, mild confusion	Obtundation, stupor, Glasgow Coma Scale ↓
Renal	UO decreasing (watch for < 0.5 mL/kg/hr)	Oliguria/anuria, rising BUN/Cr
Skin	Flushed, warm, diaphoretic	Cool, pale, mottled, cyanotic peripheries
GI	Nausea, decreased bowel sounds	Ileus, abdominal distension
Temperature	Fever (> 38.3°C) or hypothermia (< 36°C)	Persistent hypothermia (ominous sign)

Laboratory and Diagnostic Interpretation

Test	Expected Finding in Sepsis	Clinical Significance
Serum Lactate	> 2 mmol/L (severe if ≥ 4 mmol/L)	Marker of tissue hypoperfusion and anaerobic metabolism
WBC	> 12,000/mm³ or < 4,000/mm³ (or > 10% bands)	Leukocytosis (infection response) or leukopenia (severe)
CRP / Procalcitonin	Markedly elevated	Inflammatory markers; procalcitonin more specific for bacterial infection
Blood cultures × 2	May be positive (bacteremia)	Drawn before antibiotics; guide de-escalation
Creatinine / BUN	Rising above baseline	Renal involvement; AKI staging
Bilirubin	> 2 mg/dL	Hepatic dysfunction (SOFA point)
Platelets	< 100,000/mm³	Coagulopathy / DIC concern
PT / INR	Elevated	Clotting factor consumption (DIC)
ABG	Metabolic acidosis (pH < 7.35, HCO₃⁻ ↓, compensatory ↑ RR)	Reflects systemic hypoperfusion
BNP / troponin	Elevated (in septic cardiomyopathy)	Cardiac dysfunction monitoring

---

Management: The Hour-1 Bundle

The Surviving Sepsis Campaign Hour-1 Bundle (updated 2018) represents the strongest evidence-based framework for early sepsis management. Each element should be initiated as soon as sepsis is recognized, within 1 hour of identification.

Hour-1 Bundle Elements

Element	Action	Nursing Role
1. Measure lactate	Obtain serum lactate level; if > 2 mmol/L, re-measure within 2 hours	Coordinate stat lab draw; recognize critical value
2. Blood cultures × 2	Draw at least two sets from separate sites before antibiotics	Use aseptic technique; label correctly; document time
3. Broad-spectrum antibiotics	Administer IV antibiotics within 1 hour of sepsis recognition	Prepare and infuse immediately; document administration time
4. Crystalloid fluids	30 mL/kg IV crystalloid bolus for hypotension (MAP < 65) or lactate ≥ 4 mmol/L	Administer rapidly; reassess for fluid responsiveness
5. Vasopressors	Initiate norepinephrine if MAP remains < 65 mmHg after fluid resuscitation	Titrate per protocol; continuous hemodynamic monitoring

Fluid Resuscitation Principles

The initial 30 mL/kg isotonic crystalloid bolus (Lactated Ringer’s preferred over normal saline to minimize hyperchloremic acidosis) should be administered over 1–3 hours. After the initial resuscitation, fluid responsiveness should be re-evaluated using dynamic measures such as:

• Passive leg raise (PLR) test: Elevate legs 45° for 1 minute; a ≥ 10% increase in cardiac output or stroke volume suggests fluid responsiveness.
• Pulse pressure variation (PPV): > 13% variation in PPV during mechanical ventilation suggests preload-dependence.
• Point-of-care ultrasound (POCUS): Assess IVC collapsibility index and LV function.

Vasopressor Therapy

When MAP remains < 65 mmHg despite adequate fluid resuscitation, vasopressors are indicated.

Vasopressor	Mechanism	Dose Range	Nursing Considerations
Norepinephrine	α₁ > β₁ agonist (1st line)	0.01–3 mcg/kg/min IV	Central line preferred; titrate to MAP ≥ 65 mmHg
Vasopressin	V1 receptor agonist (adjunct)	0.03–0.04 units/min (fixed)	Added to reduce norepinephrine dose; do not titrate
Epinephrine	α + β agonist (2nd line or cardiac arrest)	0.01–0.5 mcg/kg/min	Increases HR and lactate — monitor closely
Dopamine	Dose-dependent α/β/dopaminergic	5–20 mcg/kg/min	Higher arrhythmia risk; use only if low risk
Phenylephrine	Pure α₁ agonist	0.5–6 mcg/kg/min	Tachycardia or norepinephrine shortage situations

Antibiotic Stewardship and De-escalation

Initial antibiotics should be broad-spectrum, covering the most likely organisms based on suspected source. De-escalation to targeted therapy should occur as soon as culture and sensitivity results return, typically within 48–72 hours. Procalcitonin levels can guide antibiotic discontinuation — a declining trend toward normal reduces the likelihood of ongoing bacterial infection.

Source Control

Identifying and controlling the infectious source is essential and should occur as soon as possible. Examples include removal of an infected central venous catheter, drainage of an abscess, or surgical debridement of necrotizing fasciitis. The nurse plays a critical role in recognizing when source control has not been achieved and escalating this concern to the medical team.

---

Ongoing Monitoring and Nursing Priorities

After the initial resuscitation, continuous nursing surveillance drives early recognition of treatment failure or new complications. Priority monitoring includes:

• Hemodynamic parameters: MAP ≥ 65 mmHg, HR trend, CVP (if applicable)
• Urine output: Target ≥ 0.5 mL/kg/hr; oliguria indicates persistent renal hypoperfusion
• Serial lactate: Goal is clearance of ≥ 10–20% per measurement; failure to clear indicates ongoing hypoperfusion
• Respiratory status: SpO₂, work of breathing, ABG — early intubation if respiratory failure is imminent
• Neurological status: GCS, delirium screening (CAM-ICU or ICDSC)
• Skin and wound assessment: Signs of worsening tissue perfusion (mottling, cyanosis)
• Fluid balance: Cumulative I&O, daily weights, signs of fluid overload (crackles, peripheral edema, worsening P:F ratio)
• Laboratory trends: Serial SOFA score, BMP, CBC, coagulation panel, LFTs

---

Complications

Multi-Organ Dysfunction Syndrome (MODS)

MODS is the progressive failure of two or more organ systems and represents the final common pathway of uncontrolled sepsis. Management is primarily supportive: mechanical ventilation for ARDS (lung-protective strategy — tidal volume 6 mL/kg IBW, plateau pressure < 30 cmH₂O), continuous renal replacement therapy (CRRT) for AKI, and pharmacological management of septic cardiomyopathy.

Disseminated Intravascular Coagulation (DIC)

DIC is characterized by simultaneous widespread microvascular clotting and hemorrhage. Nursing priorities include monitoring for both bleeding (petechiae, ecchymosis, oozing from IV sites, GI bleeding) and thrombosis (skin necrosis, limb ischemia). Treatment is directed at the underlying sepsis; blood products (FFP, platelets, cryoprecipitate) are given to manage active bleeding.

Post-Sepsis Syndrome

Survivors of sepsis frequently experience long-term sequelae including cognitive impairment, physical disability, psychiatric disorders (PTSD, depression, anxiety), and recurrent infections. Preparing patients and families for post-sepsis syndrome before discharge is an essential nursing responsibility that is often overlooked in the acute phase.

---

Pharmacological Considerations

Key drug classes and agents in sepsis management include:

Drug Category	Examples	Key Nursing Actions
Broad-spectrum antibiotics	Piperacillin-tazobactam, vancomycin, meropenem, cefepime	Check allergies; administer within 1 hr; monitor renal function for dose adjustment
Vasopressors	Norepinephrine, vasopressin, epinephrine	Central line preferred; continuous BP monitoring; titrate to MAP goal
Corticosteroids	Hydrocortisone 200–300 mg/day (if refractory shock)	Stress-dose steroids when norepinephrine > 0.25 mcg/kg/min
Insulin (glycemic control)	Regular insulin infusion	Maintain blood glucose 140–180 mg/dL; frequent glucose checks
DVT prophylaxis	Unfractionated or low-molecular-weight heparin	Assess for contraindications (DIC, active bleeding)
Stress ulcer prophylaxis	Proton pump inhibitors	Particularly important in mechanically ventilated patients

---

Patient and Family Education

Education should begin as soon as the patient’s condition allows and should be integrated throughout the hospitalization. Core teaching points include:

• What sepsis is: Explain in accessible language that sepsis is the body’s extreme response to infection that can damage organs if not treated quickly.
• Cause and source of infection: When identified, explain the primary source and why it required rapid treatment.
• Warning signs of recurrence: Teach patients to seek emergency care for fever, chills, extreme fatigue, confusion, rapid breathing, or decreased urine output in the months after discharge.
• Post-sepsis syndrome: Prepare patients and families for the possibility of physical and cognitive changes after discharge, and provide referrals to appropriate support services (rehabilitation, mental health).
• Infection prevention: Hand hygiene, wound care, dental hygiene, staying current on vaccinations (influenza, pneumococcal), and early treatment of infections.
• Medication adherence: Complete the full course of prescribed antibiotics; understand the importance of follow-up appointments.

---

Clinical Case Study

Scenario

Mr. T. is a 72-year-old male with type 2 diabetes mellitus, chronic kidney disease (stage 3), and a 10-year history of coronary artery disease. He presents to the emergency department from a skilled nursing facility with a 2-day history of decreased level of consciousness, decreased urine output, and a change in the character of urine (dark, malodorous). His daughter reports he “hasn’t been himself” since yesterday.

Vital signs on arrival:

Parameter	Value
Temperature	38.9°C (102°F)
Heart rate	118 bpm (irregular)
Blood pressure	86/52 mmHg
Respiratory rate	26 breaths/min
SpO₂	91% on room air
Glasgow Coma Scale	12 (E3V4M5)

Initial labs:

Lab	Value	Reference Range
WBC	18,400/mm³	4,500–11,000
Serum creatinine	2.8 mg/dL	0.6–1.2 mg/dL
BUN	58 mg/dL	7–20 mg/dL
Serum lactate	4.6 mmol/L	< 2.0 mmol/L
Procalcitonin	22.4 ng/mL	< 0.5 ng/mL
Platelets	88,000/mm³	150,000–400,000
Blood glucose	314 mg/dL	70–100 mg/dL
Urinalysis	Pyuria, bacteriuria, positive nitrites	—

Clinical Judgment Questions

1. Calculate this patient’s qSOFA score. What does it indicate, and what is the nurse’s immediate priority action?

Answer: qSOFA score = 3 (altered mental status + RR > 22 + SBP < 100). This score of ≥ 2 confirms high risk for sepsis-related organ dysfunction. The immediate priority is to notify the provider, activate the sepsis protocol, and initiate the Hour-1 Bundle simultaneously.

2. List the five elements of the Hour-1 Bundle and identify the correct sequencing to maximize patient safety.

Answer: (1) Measure lactate — already available at 4.6 mmol/L. (2) Draw blood cultures × 2 from separate sites before antibiotics. (3) Administer broad-spectrum IV antibiotics (empiric coverage for gram-negative urosepsis, e.g., piperacillin-tazobactam or ceftriaxone; add vancomycin if MRSA risk). (4) Initiate 30 mL/kg crystalloid bolus (≈ 2,100 mL for 70-kg patient) — Lactated Ringer’s preferred. (5) If MAP remains < 65 mmHg after fluid resuscitation, initiate norepinephrine via central access (or large-bore peripheral IV temporarily).

3. Mr. T.’s MAP after 2 L of LR is 58 mmHg. Norepinephrine is ordered. What monitoring parameters will you assess every 15 minutes?

Answer: MAP (target ≥ 65 mmHg), HR trend, urine output (target ≥ 0.5 mL/kg/hr), peripheral perfusion (skin color, temperature, capillary refill), repeat lactate in 1–2 hours, IV site (peripheral extravasation risk with vasopressors), and signs of cardiac arrhythmia (note irregular HR on arrival).

4. Two hours after initiation of treatment, repeat lactate is 3.9 mmol/L. How do you interpret this trend, and what is the significance for the patient’s prognosis?

Answer: The lactate has decreased from 4.6 to 3.9 mmol/L — a 15% reduction, meeting the ≥ 10% clearance target. This indicates a partial improvement in tissue perfusion, but the lactate remains elevated above 2 mmol/L, indicating ongoing hypoperfusion. The patient requires continued aggressive management, close monitoring, and likely ICU admission. Serial reassessment every 1–2 hours is essential.

---

NCLEX Key Points

The following high-yield concepts frequently appear in NCLEX-NG items on sepsis:

• First nursing action when sepsis is suspected: Notify the provider immediately and initiate the sepsis protocol — do not wait for lab confirmation.
• Blood cultures before antibiotics: Always draw two sets from separate sites before the first antibiotic dose, but never delay antibiotics for more than 15–20 minutes to complete culture collection.
• Lactate > 4 mmol/L = indication for the Hour-1 Bundle regardless of blood pressure.
• Vasopressor of choice in septic shock = norepinephrine (first line). Dopamine is associated with greater arrhythmia risk and is a second-line option.
• Hypothermia in the setting of infection is an ominous sign — do not be falsely reassured.
• Fluid overload risk: After the initial 30 mL/kg bolus, reassess fluid responsiveness before giving additional fluids. Fluid overload worsens outcomes.
• DIC management: Treat the underlying cause (sepsis); blood products for active bleeding — do not give FFP or platelets prophylactically based on lab values alone.
• Post-sepsis syndrome: Sepsis survivors need discharge teaching about cognitive, physical, and psychiatric sequelae, and early follow-up arrangements.
• Priority assessment parameters: MAP, urine output, mental status, and serial lactate clearance drive treatment decisions in sepsis.

---

Alignment to Accreditation and Licensure Standards

Standard Domain	Specific Standard	How This Lesson Addresses It
AACN D2 — Person-Centered Care	Individualize care to patient context, risk, and values	Patient history, risk stratification, family education, post-sepsis counseling
AACN D3 — Population Health	Apply epidemiological principles	Sepsis epidemiology, risk factor identification, infection prevention
AACN D6 — Interprofessional Collaboration	Engage healthcare team	Hour-1 Bundle team roles, ICU escalation, source control decisions
AACN D8 — Informatics and Evidence-Based Practice	Apply best evidence	Surviving Sepsis Campaign guidelines, Sepsis-3 criteria, SOFA-guided monitoring
NCLEX-NG CJMM	All six cognitive skills	Case study integrates recognize cues → analyze → prioritize → generate solutions → take action → evaluate
QSEN — Safety	Minimize patient harm	Hour-1 Bundle timing, antibiotic timing benchmarks, vasopressor escalation
QSEN — PCC	Respect patient preferences	Family communication, patient education, post-sepsis syndrome planning
QSEN — EBP	Use current evidence	Surviving Sepsis Campaign 2021, Sepsis-3 definitions, fluid responsiveness assessment

---

References

• Evans, L., Rhodes, A., Alhazzani, W., et al. (2021). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Critical Care Medicine, 49(11), e1063–e1143.
• Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801–810.
• Centers for Disease Control and Prevention. (2024). Sepsis. U.S. Department of Health and Human Services. https://www.cdc.gov/sepsis/
• American Association of Colleges of Nursing. (2021). The Essentials: Core competencies for professional nursing education. AACN.
• National Council of State Boards of Nursing. (2023). 2023 NCLEX-RN test plan. NCSBN.
• QSEN Institute. (2020). QSEN competencies: Definitions and pre-licensure KSAs. https://qsen.org/competencies/